Literature DB >> 26692492

Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity.

Viswanathan Saraswathi1, Murali Ganesan2, Curtis Perriotte-Olson2, Devika S Manickam3, Rachel A Westwood2, Matthew C Zimmerman4, Iman M Ahmad5, Cyrus V Desouza6, Alexander V Kabanov3.   

Abstract

OBJECTIVE: Endothelial cell (EC) oxidative stress can lead to vascular dysfunction which is an underlying event in the development of cardiovascular disease (CVD). The lack of a potent and bioavailable anti-oxidant enzyme is a major challenge in studies on antioxidant therapy. The objective of this study is to determine whether copper/zinc superoxide dismutase (CuZnSOD or SOD1) after nanoformulation (nanoSOD) can effectively reduce EC oxidative stress and/or vascular inflammation in obesity.
METHODS: Human aortic endothelial cells (HAECs) were treated with native- or nanoSOD for 6 h followed by treatment with linoleic acid (LA), a free fatty acid, for 6-24 h. To determine the in vivo relevance, the effectiveness of nanoSOD in reducing vascular cell activation was studied in a mouse model of diet-induced obesity.
RESULTS: We noted that nanoSOD was more effectively taken up by ECs than native SOD. Western blot analysis further confirmed that the intracellular accumulation of SOD1 protein was greatly increased upon nanoSOD treatment. Importantly, nanoSOD pretreatment led to a significant decrease in LA-induced oxidative stress in ECs which was associated with a marked increase in SOD enzyme activity in ECs. In vivo studies showed a significant decrease in markers of EC/vascular cell activation and/or inflammation in visceral adipose tissue (VAT), thoracic aorta, and heart collected from nanoSOD-treated mice compared to obese control mice. Interestingly, the expression of metallothionein 2, an antioxidant gene was significantly increased in nanoSOD-treated mice.
CONCLUSION: Our data show that nanoSOD is very effective in delivering active SOD to ECs and in reducing EC oxidative stress. Our data also demonstrate that nanoSOD will be a useful tool to reduce vascular cell activation in VAT and aorta in obesity which, in turn, can protect against obesity-associated CVD, in particular, hypertension.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Free fatty acid; NanoSOD; Obesity; Oxidative stress; Superoxide dismutase; Vascular inflammation

Mesh:

Substances:

Year:  2015        PMID: 26692492      PMCID: PMC6368064          DOI: 10.1016/j.bbrc.2015.12.027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.

Authors:  Thiyagarajan Gopal; Narendra Kumar; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Edward N Harris; Geoffrey Talmon; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

Review 2.  Enzymes as Immunotherapeutics.

Authors:  Shaheen A Farhadi; Evelyn Bracho-Sanchez; Sabrina L Freeman; Benjamin G Keselowsky; Gregory A Hudalla
Journal:  Bioconjug Chem       Date:  2018-01-31       Impact factor: 4.774

3.  Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue.

Authors:  Gopalakrishnan Natarajan; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Geoffrey A Talmon; Edward N Harris; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Alcohol       Date:  2019-01-03       Impact factor: 2.405

Review 4.  Nanoparticles in the diagnosis and treatment of vascular aging and related diseases.

Authors:  Hui Xu; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

5.  Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling.

Authors:  Gopalakrishnan Natarajan; Curtis Perriotte-Olson; Fatema Bhinderwala; Robert Powers; Cyrus V Desouza; Geoffrey A Talmon; Jiang Yuhang; Matthew C Zimmerman; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Transl Res       Date:  2017-08-15       Impact factor: 7.012

6.  Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (Angiotensin II): A Potential Role for Nrf2 (Nuclear Factor [Erythroid-Derived 2]-Like 2).

Authors:  Anyun Ma; Lie Gao; Ahmed M Wafi; Li Yu; Tara Rudebush; Wenxian Zhou; Irving H Zucker
Journal:  Hypertension       Date:  2020-09-08       Impact factor: 10.190

Review 7.  Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism.

Authors:  J Olechnowicz; A Tinkov; A Skalny; Joanna Suliburska
Journal:  J Physiol Sci       Date:  2017-09-30       Impact factor: 2.781

Review 8.  Superoxide Dismutase Administration: A Review of Proposed Human Uses.

Authors:  Arianna Carolina Rosa; Daniele Corsi; Niccolò Cavi; Natascia Bruni; Franco Dosio
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.